Francis Scarpaleggia on Questions on the Order Paper

With respect to the government’s response aimed at ensuring the safety of drug compounds to the under-dosing of chemotherapy drugs, discovered on March 20, 2013 at four Ontario hospitals: (a) what actions have been taken, with (i) drug compounders, (ii) each of the provinces and territories, in order to establish a federal regulatory framework for this sector; (b) what steps remain to be taken to successfully establish a comprehensive federal regulatory regime for drug compounders, similar to that which exists for drug manufacturers; (c) what new rules will be included with regard to purchasing protocols for compounding inputs; (d) will these protocols be equivalent to those for manufacturers; (e) how will compliance with the rules in (c) be monitored and enforced; (f) how does the government monitor and enforce manufacturing and purchasing protocols for drug manufacturers; and (g) how does the government ensure that monitoring and compliance are sufficient to ensure the safety of all Canadians who consume medications?